The DOI matches its Crossref record; 195 of the 198 references it cites were found in a registry or an index.
Iron Chelation Therapy for Malaria
Abstract
Malaria is one of the major global health problems, and an urgent need for the development of new antimalarial agents faces the scientific community. A considerable number of iron(III) chelators, designed for purposes other than treating malaria, have antimalarial activity in vitro, apparently through the mechanism of withholding iron from vital metabolic pathways of the intra-erythrocytic parasite. Certain iron(II) chelators also have antimalarial activity, but the mechanism of action appears to be the formation of toxic complexes with iron rather than the withholding of iron. Several of the iron(III)-chelating compounds also have antimalarial activity in animal models of plasmodial infection. Iron chelation therapy with desferrioxamine, the only compound of this nature that is widely available for use in humans, has clinical activity in both uncomplicated and severe malaria in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Along this line children suffering from cerebral malaria benefited from the addition of the iron chelator desferrioxamine to a standard anti-malaria treatment, as reflected by faster recurrence from coma and clearance of plasmodia, although this did not translate into a survival benefit (Gordeuk et al., 1992; Mabeza et al., 1999), although anti-plasmodial innate immune responses were positively”
From Iron at the interface of immunity and infection (2014) · cites this paper as Mabeza et al., 1999
In the citing paper
“the malarial parasite Plasmodium falciparum requires considerable iron for growth, and there is evidence that lowering the amount of available iron provides a promising route to antimalarials (e.g. [1478-1494]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1486]
In the citing paper
“On the other hand, mild iron deficiency is protective against malaria-causing Plasmodium falciparum infection (Mabeza et al., 1999; Gwamaka et al., 2012).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Mabeza et al., 1999
In the citing paper
“In support of this notion, host Fe overload is associated with poor clinical outcomes in a number of infectious diseases such as AIDS (i.e., co-infections resulting from HIV-driven immunodeficiency), malaria, and tuberculosis [19][20][21][22]”
From The Iron age of host–microbe interactions (2015) · cites this paper as [20]
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Nitric oxide synthases: Roles, tolls, and controls
Nathan, C., & Xie, Q.-W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,918
Free radicals, antioxidants, and human disease: where are we now?
Halliwell, B. B., Gutteridge, J. M. C., & Cross, C. E. (1992) · PubMed · Cited by 2,610
Glutamate, nitric oxide and cell-cell signalling in the nervous system
Garthwaite, J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90022-m · Cited by 2,402
NITRIC OXIDE: A Physiologic Messenger Molecule
Bredt, D. S., & Snyder, S. H. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.001135 · Cited by 2,368
Nitric oxide: A cytotoxic activated macrophage effector molecule
Hibbs, J. B., Taintor, R. R., Vavrin, Z., & Rachlin, E. M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80015-9 · Cited by 2,030
Stuehr, D. J., & Nathan, C. F. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.5.1543 · Cited by 1,744
Research works printed but not linked: 6
- Alvarez-Hernandez, 1989, Induction of hypoferremia and modulation of macrophage iron, Lab. Invest., 61, 319
- Clarke, 1990, Hydrophobic iron chelators as new antimalarial drugs, Clin. Res., 38, 300A
- MacPherson, 1985, Human cerebral malaria, Am. J. Pathol., 119, 385
- Molyneux, 1989, Clinical features and prognostic indicators in paediatric cerebral malaria, J. Med. New Series, 71, 441
- Murray, 1975, Refeeding malaria and hyperferraemia, Lancet i:, 653–654
- Pattanapanyasat, 1997, Flow cytometric assessment of hydroxypyridone iron chelators on in vitro growth of drug-resistant malaria, Cytometry, 27, 84, 10.1002/(sici)1097-0320(19970101)27:1<84::aid-cyto11>3.0.co;2-o · doi:10.1002/(sici)1097-0320(19970101)27:1<84::aid-cyto11>3.0.co;2-o
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Ferreira, J. F. S., Luthria, D. L., Sasaki, T., & Heyerick, A. (2010) · Molecules · doi:10.3390/molecules15053135 · Cited by 531
Iron availability and infection
Weinberg, E. D. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.07.002 · Cited by 516
“Deferoxamine (DFO) has been tested as an adjunct drug in malaria with limited success [73].”
BackgroundHomeobox genes and gut development
Beck, F., Tata, F., & Chawengsaksophak, K. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200005)22:5<431::aid-bies5>3.0.co;2-x · Cited by 110
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332
Metadata
- Authors
- Mabeza, G. F., Loyevsky, M., Gordeuk, V. R., & Weiss, G.
- Affiliations
- University of Zimbabwe (ZW)
- George Washington University (US)
- Universität Innsbruck (AT)
- Corresponding author
- Gordeuk, Victor R
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 81
- Issue
- 1
- Pages
- 53-75
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W205885959
- Cited by
- 111
- References
- 198
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 7 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 10 · 2013: 7 · 2012: 4
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- iron chelation therapy, malaria, antimalarial drugs, Plasmodium, deferoxamine, iron sequestration, severe malaria
- MeSH terms
- Animals, Humans, Iron, Plasmodium falciparum, Chelation Therapy, Malaria, Falciparum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iron Chelation Therapy for Malaria. https://app.cochat.ai/papers/10.1016/s0163-7258(98)00037-0
- The paper
- Mabeza, G. F., Loyevsky, M., Gordeuk, V. R., & Weiss, G. (1999). Iron Chelation Therapy for Malaria. Pharmacology & Therapeutics. https://doi.org/10.1016/s0163-7258(98)00037-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.